1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Transcultural, transdiagnostic and concurrent validity of a Control Scale of ME/CFS, FM & Type 1 Diabetes

Discussion in 'Psychosomatic news - ME/CFS and Long Covid' started by MeSci, Mar 30, 2019.

  1. MeSci

    MeSci Senior Member (Voting Rights)

    Messages:
    4,492
    Location:
    Cornwall, UK
    Source: London South Bank University

    Preprint Clinical Psychology and Psychotherapy

    Date: March 25, 2019 / April 21, 2020

    URL: http://researchopen.lsbu.ac.uk/3060/

    Transcultural, transdiagnostic, and concurrent validity of a revised Metacognitions about Symptoms Control Scale
    ----------------------------------------------------------
    Fernie, B.A., Aoun, A., Kollmann, J., Spada, M.M., and Nikcevic, A.V.

    - King's College London, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychology, London, UK

    Abstract

    Anxiety and depression add to the burden of Chronic Fatigue Syndrome (CFS), Fibromyalgia (FM), and Type 1 Diabetes Mellitus (T1DM).

    Metacognitions play a role in this distress. The Metacognitions about Symptoms Control Scale (MaSCS) measures metacognitive beliefs regarding symptoms but has weaknesses. The current study created a revised MaSCS (MaSCS-R) in English, German, and Arabic versions using CFS, FM, and T1DM samples, and examined the transcultural, transdiagnostic, and concurrent validity of metacognitions about symptom control. This study used data from a total of 563 participants clinically diagnosed with CFS (n=124; English), FM (n=348; German), or T1DM (n=91; Lebanese). CFS and FM data had been used in earlier published studies but were subjected to new analyses. CFS data was used to create the English version of the MaSCS-R, and FM and T1DM data for German and Arabic versions.

    Metacognitions about worry, anxiety, depression, and symptom severity were measured. The three MaSCS-R versions, consisting of two factors (each with four items), had adequate psychometric properties, possessing configural and metric invariance. Metacognitive factors were associated with distress and symptom severity in all three samples. Metacognitions about symptom control have transcultural, transdiagnostic, and concurrent validity.

    --------
    (c) 2019 London South Bank University
     
  2. Trish

    Trish Moderator Staff Member

    Messages:
    52,217
    Location:
    UK
    How can they tell what is transcultural and what is transdiagnostic if they only have a single sample for each condition, each in a different cultural setting?

    Curious about what on earth metacognitions are and what their 'research instrument' involved, I found this paper from 2014 which lists the questions on page 16 tables 1 and 2. It's all the usual stuff about symptom focusing, rumination, feeling in control etc.
     
  3. James Morris-Lent

    James Morris-Lent Senior Member (Voting Rights)

    Messages:
    903
    Location:
    United States
    Who knew people thought about their existence. Thank goodness the luminaries from Kings College London Institute of Psychiatry, Psychology, and Neuroscience are here to shed such light on the shadowy depths of the human condition.
     
    MEMarge, shak8, Amw66 and 6 others like this.
  4. TiredSam

    TiredSam Committee Member

    Messages:
    10,496
    Location:
    Germany
    I never metacognition I didn't like.
     
    MEMarge, merylg, shak8 and 5 others like this.
  5. shak8

    shak8 Senior Member (Voting Rights)

    Messages:
    2,218
    Location:
    California
    About as fruitful as trying to parse an inane philosophical tract. Psychiatrists live with the fairies.
     
    MEMarge and Trish like this.

Share This Page